Rafferty Asset Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,520
| Closed | -$980K | – | 1085 |
|
|
2023
Q2 | $980K | Buy |
14,520
+4,692
| +48% | +$317K | 0.01% | 821 |
|
|
2023
Q1 | $4.58M | Sell |
9,828
-553
| -5% | -$258K | 0.03% | 400 |
|
|
2022
Q4 | $4.16M | Buy |
10,381
+1,268
| +14% | +$508K | 0.03% | 416 |
|
|
2022
Q3 | $2.96M | Buy |
9,113
+3,026
| +50% | +$984K | 0.03% | 418 |
|
|
2022
Q2 | $1.61M | Sell |
6,087
-5,000
| -45% | -$1.32M | 0.01% | 530 |
|
|
2022
Q1 | $3.33M | Buy |
11,087
+250
| +2% | +$75.1K | 0.02% | 483 |
|
|
2021
Q4 | $3.82M | Sell |
10,837
-155
| -1% | -$54.6K | 0.02% | 475 |
|
|
2021
Q3 | $2.81M | Buy |
10,992
+6,988
| +175% | +$1.79M | 0.02% | 520 |
|
|
2021
Q2 | $2.67M | Buy |
4,004
+213
| +6% | +$142K | 0.02% | 552 |
|
|
2021
Q1 | $3.29M | Buy |
3,791
+2,882
| +317% | +$2.5M | 0.02% | 428 |
|
|
2020
Q4 | $843K | Sell |
909
-973
| -52% | -$902K | 0.01% | 552 |
|
|
2020
Q3 | $1.94M | Buy |
1,882
+881
| +88% | +$906K | 0.02% | 425 |
|
|
2020
Q2 | $1.01M | Buy |
1,001
+747
| +294% | +$757K | 0.01% | 537 |
|
|
2020
Q1 | $221K | Sell |
254
-1,909
| -88% | -$1.66M | 0.01% | 502 |
|
|
2019
Q4 | $2.32M | Sell |
2,163
-2,822
| -57% | -$3.03M | 0.04% | 338 |
|
|
2019
Q3 | $4.61M | Buy |
4,985
+124
| +3% | +$115K | 0.07% | 160 |
|
|
2019
Q2 | $5.49M | Buy |
4,861
+1,246
| +34% | +$1.41M | 0.1% | 142 |
|
|
2019
Q1 | $4.91M | Buy |
+3,615
| New | +$4.91M | 0.08% | 141 |
|